Posted inClinical Updates Medical News
Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease
Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.